Diafert for Embryo Selection and Fertility Improvement (DESTINy)

NCT02593513 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2017-08-01

No results posted yet for this study

Summary

Prospective, single-center, single-blind, randomized, controlled, two-arm, interventional study.

Conditions

Interventions

DEVICE

Daifert

PROCEDURE

Control Group

Control - Morphological Assessment

Sponsors & Collaborators

  • Forest Laboratories

    lead INDUSTRY

Principal Investigators

  • Tennador Sanderson · Forest Laboratories, an affiliate of Allergan plc

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-26
Primary Completion
2017-02-22
Completion
2017-04-07

Countries

  • Hungary

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02593513 on ClinicalTrials.gov